Cheryle buys HALO 10.07: Top Analyst Upgrades and Downgrades: Apache, Apple, HP, Qualcomm, Sprouts and More
Halozyme Therapeutics Inc. (NASDAQ: HALO) was raised to Buy from Neutral and given a $16 price target (versus a $9.39 close) by UBS. HollySys Automation Technologies Ltd. (NASDAQ: HOLI) was started with a Buy rating and $26 price target (versus a $22.54 .. ...
22 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home